• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK BIOTECH BIODESIGN DURAPLASTY GRAFT; DURALPLASTY GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK BIOTECH BIODESIGN DURAPLASTY GRAFT; DURALPLASTY GRAFT Back to Search Results
Model Number G34979
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Abscess (1690); Unspecified Infection (1930)
Event Date 09/01/2018
Event Type  Injury  
Manufacturer Narrative
A review of the device lot history record indicated the device was manufactured to specifications.A total of 10 devices was produced from the lot.A review of the cbi complaint database did not reveal any additional complaints involving the reported lot number.Per the ifu, the device is supplied sterile to the end user.The device should be used "with caution in infection regions." infection is noted amongst the list of potential complications.The root cause, of the abscess and infection, is not likely device related.Such an occurrence could be procedure related and/or acquired post operatively.Cook biotech incorporated has a validated sterilization cycle with a sterility assurance level of (sal) 10^-6.The validated sterility cycle and all parameters of all devices are verified prior to release for distribution.
 
Event Description
Professor (b)(6) performed an endoscopic transnasal repair of a skull base fracture in the anterior ethmoid roof.The (b)(6) 2018 procedure included implanting a biodesign duraplasty graft in the (b)(6) female patient.Prior to surgery the patient presented with a spontaneous csf leak and had a known history of generalized seizures.The patient had an uneventful recovery and was seen post repair regularly.On (b)(6) 2018, the patient presented with a generalized grand-mal seizure.An urgent brain ct showed a possible small intracranial abscess at the graft site.The patient was admitted to the icu and underwent emergency surgery to explant the graft.The patient was in the hospital for 7 days on antibiotics.The patient recovered and was discharged.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIODESIGN DURAPLASTY GRAFT
Type of Device
DURALPLASTY GRAFT
Manufacturer (Section D)
COOK BIOTECH
1425 innovation place
west lafayette IN 47906
Manufacturer (Section G)
COOK BIOTECH INCORPORATED
1425 innovation place
west lafayette IN 47906
Manufacturer Contact
perry guinn
1425 innovation place
west lafayette, IN 47906
7654973355
MDR Report Key7978687
MDR Text Key124129580
Report Number1835959-2018-00012
Device Sequence Number1
Product Code GXQ
UDI-Device Identifier10827002349794
UDI-Public(01)10827002349794(17)190419(10)LB1033082
Combination Product (y/n)N
Reporter Country CodeZA
PMA/PMN Number
K131015
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 10/16/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/18/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/19/2019
Device Model NumberG34979
Device Catalogue NumberENT-CBD-5X5
Device Lot NumberLB1033082
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/11/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/26/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
NONE WERE REPORTED BY THE COMPLAINANT.
Patient Outcome(s) Required Intervention;
Patient Age21 YR
Patient Weight65
-
-